Login / Signup

Serological Investigation of Persistent Villous Atrophy in Celiac Disease.

Changlin GongClaudia SaboritXin LongAo WangBeishi ZhengHoward ChungSuzanne K LewisSuneeta KrishnareddyGovind BhagatPeter H R GreenXiao-Fei Kong
Published in: Clinical and translational gastroenterology (2023)
Autoantibody levels were high only for tTG antibodies, which performed well in initial CeD diagnosis, but suboptimally for VA prediction during follow-up, as 14.6% of the follow-up patients with VA had low tTG-IgA. Increasing dilution improved tTG-IgA quantification, particularly when the antibody levels were extremely high, but did not significantly improve VA detection. Among those with low tTG-IgA and persistent VA, high proinflammatory cytokines were observed in two patients. Median LDL-C levels were significantly lower in the VA CeD group (P = 0.03). Apolipoprotein levels were similar in patients with and without VA, but diverged between those on a gluten-free diet (GFD) or not.Conclusions: tTG-IgA as a biomarker is suboptimal for villous atrophy prediction while on a GFD. Persistent villous atrophy is associated with low LDL-C levels, and partially related to persistent high proinflammatory cytokines.
Keyphrases
  • celiac disease
  • end stage renal disease
  • chronic kidney disease
  • physical activity
  • peritoneal dialysis
  • patient reported outcomes
  • gas chromatography